[Clinical evaluation of a new antihistaminic: HS-592].
D001249:Asthma / Q000188:drug therapy; D002648:Child; D003875:Drug Eruptions / Q000188:drug therapy; D005069:Evaluation Studies as Topic; D005260:Female; D006634:Histamine H1 Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D006969:Hypersensitivity, Immediate / Q000188:drug therapy*; D008297:Male; D010406:Penicillins / Q000009:adverse effects; D011759:Pyrrolidines / Q000009:adverse effects / Q000627:therapeutic use*; D006255:Rhinitis, Allergic, Seasonal / Q000188:drug therapy
D006634:Histamine H1 Antagonists; D010406:Penicillins; D011759:Pyrrolidines
Evaluación clínica de un nuevo antiistamínico: el HS-592.